Homepage / AuNP Research Blog / Gold Nanoparticle Cancer Research Report #13



Click to Request a Free Appraisal Kit, Please tell them this website sent you
ExpressGoldCash - 4.9 star - Customer Reviews


Gold Nanoparticle Cancer Research Report
#13


Originally Posted on 12/19/2019 @ 3:56 pm EST

Last Edited on 3/26/2025

by Steven Warrenfeltz









follow us in feedly
Gold Nano Blog

Hello,

Gold Nanoparticle Cancer Research is a non-invasive cancer treatment that kills cancer without harmful side effects.

In this report, you'll find summaries of the most promising and compelling studies from the past year (2019) in regards to gold nanoparticle medical research.

Below is a glimpse into what you'll find in this report:


  • Preliminary Results Released for Naomi J. Halas / Nanospectra’s Nanoparticle Light Therapy for Prostate Cancer

  • Harvard Medicine Develops Gold "Nanovehicles" to Suppress Breast Cancer

  • Researchers improve CRISPR Delivery with Gold Nanoparticles

  • Gold Nanoparticle Delivery of Mesothelioma Drugs has its Advantages over Current Methods

  • Dual Therapies become a New Double Action Weapon Against Breast Cancer



First Results from
Naomi J. Halas / Nanospectra’s Gold Nanoshell Light Therapy for Prostate Cancer

Dr. Naomi Halas, a researcher at Rice University, has been conducting experiments on the properties of gold nanoparticles for nearly thirty years.

Q and A with a Medical Pioneer...Naomi J. Halas Ph.D.

In November of 2018, Dr. Naomi Halas answered a few questions for a blog post on this site, see it here.

In one of Dr. Halas's answers, she stated that her research is presently in human clinical trials. The research revolved around using gold nanoshells to remove tumors from a man's prostate.

Nanospectra Biosciences is a company founded by Dr. Naomi Halas and bioengineer Jennifer West of Duke University that is providing nanoshells for clinical trials.

Human Clinical Trials
Preliminary Results

The human clinical trials are being conducted by Dr. Rastinehad of Mt. Sinai Hospital in New York and by Steven E. Canfield of UT Health in Houston, TX. 

In August of 2019, these preliminary results were reported:

The pilot device study reports effectiveness and safety data from Mt. Sinai’s first 16 enrolled subjects diagnosed with localized, low to intermediate risk prostate cancer.

After GSN infusion and targeted laser ablation, patients underwent MRI of the prostate at 48 – 72 hours, followed by post-procedure mpMRI/US targeted fusion biopsies at three and 12 months, as well as a standard 12-core systematic biopsy at 12 months.

GSN-mediated focal laser ablation was successfully achieved in 94% (15 of 16) patients.

At the one-year study endpoint, 87.5% (14/16 lesions) were negative for tumor as confirmed by pathology and considered successful treatment outcomes.

Proceedings of the National Academy of Sciences (PNAS)

Furthermore, Dr. Rastinehad expressed his feelings about the study in the statement below:

“The early results are very encouraging and with feasibility study enrollment now complete we anticipate publishing results at the initial three month endpoint for mpMRI targeted fusion biopsies for the entire 45 subject population early next year.” (2020)


Learn more about this study by following one the two links below:

Gold nanoshell-localized photothermal ablation of prostate tumors in a clinical pilot device study - Proceedings of the National Academy of Sciences (PNAS)

Nanospectra’s Nanoparticle Light Therapy for Prostate Cancer Shows Promise - biospace

Nanospectra Biosciences Announces PNAS Publication of Initial Results of First Clinical Trial of Gold Nanoshell-Localized Photothermal Ablation of Prostate Tissue - Nanospectra

3/15/22: Rice University professor waits on FDA to approve what she hopes will be a cure for prostate cancer - Eye-Witness News abc13



Harvard Medicine Develops
Gold "Nano Vehicle" to Suppress Breast Cancer

Many cancer therapies affect all of a patient's cells because the drugs cannot differentiate between healthy and cancerous cells.  However, in this study, Harvard Medical researchers have found a way around this problem.

Researchers from the Harvard John A. Paulson School of Engineering and Applied Sciences (SEAS) have developed a multi-functional gold-nano-vehicle with enhanced drug loading and delivery efficiency capabilities.

gold vehicle

The nano-vehicle that Harvard has developed has high loading capacities for both hydrophobic and hydrophilic drugs.

Gold nano-vehicles demonstrated effective drug delivery efficiency in mice, accumulating at tumors after i.v. injection, affecting only cancer cells, not healthy ones.

The triple-drug-loaded gold nano-vehicle successfully delivered its payload to breast cancer in mice, suppressing cancer cells by 94% and 87% at total dosages of 5 mg/kg and 2.5 mg/kg, respectively, through synergy.

Nano-vehicles with nano-gold's photo-thermal properties effectively inhibit multi-drug resistance using near-infrared laser irradiation.

Mingtan Hai, a visiting professor at SEAS and co-author of the study, said the following about the findings in the research.

“We can use these hybrid nano-vehicles to deliver a new combination of anticancer drugs in mice through intravenous injection and see remarkable effectiveness against breast tumors.”

“This work enables the use of previously undeliverable compounds in cancer therapy and forms a foundation for further development in a broad range of biomedical applications.”

- Harvard John A. Paulson School of Engineering and Applied Sciences


To Learn more about this study follow the links below:

New drug delivery system suppresses tumors in mice - Harvard John A. Paulson School of Engineering and Applied Sciences

Photothermal-responsive nanosized hybrid polymersome as versatile therapeutics codelivery nanovehicle for effective tumor suppression - PNAS




Click to Request a Free Appraisal Kit, Please tell them this website sent you
ExpressGoldCash - 4.9 star - Customer Reviews




Researchers improve CRISPR Delivery with Gold Nanoparticles

Although this research study is not about cancer, it does offer you a glimpse into how science is using Gold Nanoparticles to make CRISPR more efficient.

'CRISPR' stands for Clustered Regularly Interspaced Short Palindromic Repeats. It is a genome-editing tool that is centered on splicing DNA.

In this next study, a team of researchers from Fred Hutchinson Cancer Center improved the delivery of CRISPR with Gold Nanoparticles to edit genes related to HIV and sickle cell anemia.

dna

CRISPR-Cas9 has had many good results in several lab-controlled research studies; however, one big issue with CRISPR is getting it to its expected destination in a living specimen.

Furthermore, researchers have found that the longer the CRISPR-Cas9 DNA-editing tool is in the body, it becomes a threat to the body because it could make unwanted 'edits.'

In this study, researchers loaded gold nanoparticles with the CRISPR gene-editing tool, allowing the nanoparticles to deliver and deposit CRISPR into blood stem cells.

After CRISPR's delivery was made, it altered genes related to HIV and certain blood disorders. Researchers said that "it’s a promising step toward addressing CRISPR’s critical delivery problems."

Senior scientist Dr. Jennifer Adair of Fred Hutchinson stated the following about using gold nanoparticles for the delivery of CRISPR.

"As efficient couriers, they (gold nanoparticles) could reduce the need for engineered viruses and specialized research centers. And that could help make these emerging, high-tech treatments accessible and affordable."

“Gene therapy has a lot of potential across many diseases, but the process we have right now is just not feasible in every place in the world.” 

“We want to end up delivering gene therapy in a syringe. This gold nanoparticle represents the first possibility we have to do that for blood stem cells.”

- Dr. Jennifer Adair of Fred Hutchenson


To Learn more about this study from Fred Hutchenson, 'click' this link: Special delivery: Gold nanoparticles ship CRISPR cargo - Fred Hutch.org




Gold Nanoparticle Delivery of Mesothelioma Drugs has its Advantages over Current Methods


Malignant pleural mesothelioma (MPM) is a rare but very aggressive form of cancer.

Mesothelioma lungsMesothelioma in a lung

Pemetrexed (Pe) is a rare chemotherapy drug used to combat cancer, despite its limited effectiveness.

In this study, researchers in Italy used gold nanoparticles to help Pemetrexed (Pe) to be more effective at stopping this rare form of cancer.

The study revealed that the administration of gold nanoparticles with Pemetrexed (Pe) significantly reduced the cell viability and mobility of cancer cells.  Below are notes taken from the researcher's experiments; they found that gold nanoparticles greatly enhanced the chemo drug's effectiveness:

  • that both cell viability and motility were significantly affected by nanoparticle treatment compared to Pemetrexed (Pe) administered alone.
  • Apoptotic rate (cell death) and ROS production were significantly higher in the presence of nanoparticles.
  • Clonogenic capacity (the ability to grow) was completely inhibited following nanoparticle internalization.

- Dove Press

The study's results were as follows:

  • Gold Nanoparticle in combination with Pemetrexed (Pe) (GNP-HCPe) treatment displays in vitro antineoplastic action (halting the effects of a tumor) and is more effective than Pe alone in inhibiting MPM cell line malignant phenotype.
  • The innovative use of specifically targeted GNPs opens the perspective of local intrapleural administration to avoid normal cell toxicity and enhance chemotherapy efficacy.

- Dove Press


The research findings can be further accessed through the provided links.

Gold Nanoparticle Delivery of Mesothelioma Drugs Shows Significant Advantage - Mesothelioma.net

Pemetrexed-loaded nanoparticles targeted to malignant pleural mesothelioma cells: an in vitro study - Dove Press


Dual Therapies become a
New Double Action Weapon Against Breast Cancer


In this last study, researchers from the University of Delaware devised an effective way to fight triple-negative breast cancer.  Triple-negative breast cancer is a form of breast cancer that accounts for 10 to 20 percent of patients.

University of Delaware researchers Emily Day and Joel Rosenthal have combined two minimally invasive therapies to become a new powerful weapon against this type of breast cancer.

The short video below offers an animated and informative explanation of Dr. Day and Rosenthal's research.


See the full article about the University of Delaware's Research here: NEW WEAPON AGAINST BREAST CANCER - The University of Delaware



Click to Request a Free Appraisal Kit, Please tell them this website sent you
ExpressGoldCash - 4.9 star - Customer Reviews



Thank You for your Time.

Take Care & God Bless,

Steve




Other pages, on this Guide, that you
may like...






Sunshine Minting, Inc (SMI)

Bullion Manufacturer

sunshine mint








SD Bullion

Bretton Woods

Establishing the Gold Standard of the

20th Century

Bretton Woods



Johnson Matthey

Bullion Refiner

Johnson Matthey

SilverGoldBull



Valentine's Day Gabriel Fine Jewelry





Walmart
Affiliate Ad














Home Page

FBIG - Home Page Screenshot

with Bullion Market News










Click to Request a Free Appraisal Kit, Please tell them this website sent you
ExpressGoldCash - 4.9 star - Customer Reviews






Visit  the  Homepage



Notice:

The charts, commentary, and information on the Free-Bullion-Investment-Guide.com are in no way an endorsement of how you should invest or divest.




Please Donate to
Support this Guide

& Paypal

Thank You for
Your Support







Free Bullion Investment Guide









Free-Bullion-Investment-Guide "Search"
search engine by freefind advanced


Search - Magnify Glass






Enjoy this page? Please pay it forward. Here's how...

Would you prefer to share this page with others by linking to it?

  1. Click on the HTML link code below.
  2. Copy and paste it, adding a note of your own, into your blog, a Web page, forums, a blog comment, your Facebook account, or anywhere that someone would find this page valuable.
15 Years of Service Banner of the Free Bullion Investment Guide (March 11, 2011)<br>(Ad Gloriam Dei = For the Glory of God = Jesus Christ)

This website is best viewed on a desktop computer.

Affiliate Links - Disclosure


Money Metals Exchange



Donate to
Keep this Guide Online

& Paypal

Thank You for
Your Support




Free Bullion Investment Guide

follow us in feedly
with Feedly



search

   Search the Guide

search engine by freefind advanced



U.S. Federal Reserve Statistics



Royal Mint (UK) - The Original Maker

1838 Victoria Gold Sovereign
First Sovereign issued during Victoria’s reign Wyon

The Royal Mint (U.K.) 

Delivery Rates



recent guide updates

Daily

Bullion News on the Homepage



2027 

United Kingdom

Gold and Silver

Britannia





November 2026

Newsletter




2027 U.K. Gold Sovereign  Updates

2027 Great Britain (UK) - Full Gold Sovereign Bullion Coin - reverse side showing edge



Updates for 

Australian Lunar

Gold, Silver, and Platinum Bullion Coins

Gold:

2026 - Australian Gold Lunar Bullion Coin - Year of the Horse - Series III - Reverse side

Silver:

2026 Australia Lunar Silver bullion coin - Year of the Horse - Series III - Reverse side

Platinum:

2026 Australia Lunar Silver bullion coin - Year of the Horse - Series III - Reverse side



2026 Silver Australian Koala

Photos & Mintage Update

2026 - 1 oz. Australian Silver Koala Bullion Coin - Reverse side - showing Edge



Updated Mintages and 2026 Photos for

Australian Gold, Silver, and Platinum Kangaroos

Gold Australian Kangaroos:

2026 1 oz. Gold Australian Kangaroo - Reverse side - showing reeded edge

Silver Australian Kangaroo:

2026 1oz. Australian Kangaroo Silver bullion coin - reverse side

Platinum Australian Kangaroo:

2026 1oz. Australian Platinum Kangaroo bullion coin - reverse



2026 Silver Australian Kookaburra 

Photo & Mintage Update

2026 1oz. Australia Kookaburra Silver bullion coin - reverse side - showing reeded edge





Archangel Raphael
~
The Angel of Healing

Archangel Raphael ~ The Angel of Healing



Cancer Awareness Information & Resources

Cancer Awareness Month Ribbon with FBIG Gold-Nano Logo



Help Us Expand our Audience by forwarding our link

www.free-bullion-investment-guide.com.

Thank You!



Last Month's

Best News

In No Particular Order

October 2026



The 60/40 Portfolio Meets Its Match: Why Commodities Are Becoming the Third Pillar of Diversification - Goldman favours a more permanent role for commodities - The Dark Side of the Moon (substack)

Precious Metal Royalty Companies on Track To Meet Full-Year Guidance - The Gold Report

Info~Graphic: Ranked: The Top Currencies Used in Global Payments - Visual Capitalist

Germany Debases Commemoratives - Soaring silver prices have prompted Germany to reduce the precious metal content of its commemorative coins, continuing a centuries-old practice of adjusting coinage to economic realities - Numismatic News

The 2026 Gold Nations Report: Which Countries Hold the Most Gold and Why It Matters - The Gold Bullion Co.

(.pdf) In Gold We Trust Report: Monthly Gold Compass October 2026 - Contents: Gold, Silver, Mining Stocks, Macro Analysis, and Proprietary Models - incrementum

Royal Mint Marks Four Decades of Gold & Silver Britannia Bullion Coin Anniversaries - The Royal Mint (U.K.)

eBay Extends Authenticity Guarantee to Coins - Numismatic News

Info~Graphic: Seven Events That Shaped a Century of Gold Prices - IN TODAY'S MONEY, AN OUNCE IS WORTH ALMOST FIVE TIMES WHAT IT WAS IN 1934 - MINING VISUALS

Weak September Jobs Report Just Stalled the Fed's Hiking Cycle, Not Started a Cutting One - Start Up Fortune

Charts Report: In Gold We Trust Report 2026 Chartbook - incrementum

Over The Past 55 Years, American's Standard Of Living Has Fallen Much More Than Most People Realize - In 1971, the median household income was $9,030, or 220 ounce of gold. In 2025, the median household income was $87,460, of just 25 ounces of gold- ZeroHedge

Silver shortage could flip to surplus in 2027: Deutsche - MINING.COM

(.pdf) Report: October 2026 - Monthly Gold Monitor - STATE STREET INVESTMENT MANAGEMENT

US Mint Gold Coin Sales Plunge to Lowest Level Since 2000 - SILVERTRADE

Info~Graphic: The World's 20 Largest Primary Silver Mines by 2025 Output - Mining Visuals

Gold Hasn’t Forgotten the Rules. The Market Changed the Game - The Dark Side of the Boom

(.pdf) Report: Gold Mining Company Peer Group Analysis: 2nd Quarter 2026 - Contents: Production & Cost Statistics, Producer Margins, Capital Expenditure, Cash Flow Analysis, Balance Sheet Analysis, Investor Returns, Market Ratios - Metals Focus

U.K. Debt Will Be Repaid - But What Will the Money Be Worth? - Voima Gold

Core Inflation Holds Steady in September, Energy Costs Push CPI Higher - mrcNewsBusters

GOLD FRAUD: Precious Metals “Courier Fraud” Becoming More Common - A growing form of fraud is putting precious metals dealers and their customers on alert as scammers persuade victims to buy gold for nonexistent investigations  - Numismatic News

The Financial Times "We don’t understand the gold price" - FT - Alphaville

Democratic Socialism Demolished Europe - Daniel Lacalle

All Articles were Originally Posted on the Homepage

Gold Nanoparticle Cancer Research

Swiss Researchers Use Gold to Pinpoint the Location of Cancer Cells - Money Metals Exchange

Sunlight Helps Vincristine Form Drug-Bearing Gold Nanoparticles in Five Minutes - AZONANO

Gold nanoparticles under the laser: a review maps the road from clean synthesis to cancer theranostics - BioEngineer

Gold nanoparticles show promise as dual cancer imaging and therapy tools - BioEngineer

Click this link to Learn more about Gold Nanoparticle Cancer Research 


All Articles were Originally Posted on the Homepage







99.99% Pure,100% Insured, Buy Now!